Mainz Biomed N.V. revenue for the last year amounted to 1.05 M USD, the most of which — 893.99 k USD — came from its highest performing source at the moment, Genetic Diagnostic Testing, the year earlier bringing 895.48 k USD. The greatest contribution to the revenue figure was made by Germany — last year it brought Mainz Biomed N.V. 893.99 k USD, and the year before that — 895.48 k USD.